Cargando…

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Aas, Christer Frode, Vold, Jørn Henrik, Gjestad, Rolf, Skurtveit, Svetlana, Lim, Aaron Guanliang, Gjerde, Kristian Varden, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912462/
https://www.ncbi.nlm.nih.gov/pubmed/33639969
http://dx.doi.org/10.1186/s13011-021-00354-1
_version_ 1783656582528106496
author Aas, Christer Frode
Vold, Jørn Henrik
Gjestad, Rolf
Skurtveit, Svetlana
Lim, Aaron Guanliang
Gjerde, Kristian Varden
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
author_facet Aas, Christer Frode
Vold, Jørn Henrik
Gjestad, Rolf
Skurtveit, Svetlana
Lim, Aaron Guanliang
Gjerde, Kristian Varden
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
author_sort Aas, Christer Frode
collection PubMed
description BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017–2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (− 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-021-00354-1.
format Online
Article
Text
id pubmed-7912462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79124622021-03-02 Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway Aas, Christer Frode Vold, Jørn Henrik Gjestad, Rolf Skurtveit, Svetlana Lim, Aaron Guanliang Gjerde, Kristian Varden Løberg, Else-Marie Johansson, Kjell Arne Fadnes, Lars Thore Subst Abuse Treat Prev Policy Research BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospective cohort study of 707 participants with severe SUD across nine opioid-agonist-therapy outpatient clinics and low-threshold municipality clinics in Norway, during 2017–2020. Descriptive statistics were derived at baseline and reported by means and standard deviation (SD). A linear mixed model analysis was used to assess the impact of substance use patterns and sociodemographic factors on SCL-10 sum score with beta coefficients with 95% confidence intervals (CI). RESULTS: Mean (SD) SCL-10 score was 2.2 (0.8) at baseline with large variations across patients. We observed more symptoms of mental health disorders among people with frequent use of benzodiazepines (beta 3.6, CI:2.4;4.8), cannabis (1.3, CI:0.2;2.5), opioids (2.7, CI:1.1;4.2), and less symptoms among people using frequent stimulant use (− 2.7, CI:-4.1;-1.4) compared to no or less frequent use. Females (1.8, CI:0.7;3.0) and participants with debt worries (2.2, CI:1.1;3.3) and unstable living conditions (1.7, CI:0.0;3.3) had also higher burden of mental health symptoms. There were large individual variations in SCL-10 score from baseline to follow-up, but no consistent time trends indicating change over time for the whole group. 65% of the cohort had a mean score > 1.85, the standard reference score. CONCLUSIONS: People with SUD have a considerable burden of mental health symptoms. We found no association between substance use patterns and change in mental health symptoms over time. This could suggest that the differences observed were indicating flattening of effects or self-medication to a larger degree than medication-related decline in mental health. This call for better individualized mental health assessment and patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-021-00354-1. BioMed Central 2021-02-27 /pmc/articles/PMC7912462/ /pubmed/33639969 http://dx.doi.org/10.1186/s13011-021-00354-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Aas, Christer Frode
Vold, Jørn Henrik
Gjestad, Rolf
Skurtveit, Svetlana
Lim, Aaron Guanliang
Gjerde, Kristian Varden
Løberg, Else-Marie
Johansson, Kjell Arne
Fadnes, Lars Thore
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title_full Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title_fullStr Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title_full_unstemmed Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title_short Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
title_sort substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in norway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912462/
https://www.ncbi.nlm.nih.gov/pubmed/33639969
http://dx.doi.org/10.1186/s13011-021-00354-1
work_keys_str_mv AT aaschristerfrode substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT voldjørnhenrik substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT gjestadrolf substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT skurtveitsvetlana substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT limaaronguanliang substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT gjerdekristianvarden substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT løbergelsemarie substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT johanssonkjellarne substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT fadneslarsthore substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway
AT substanceuseandsymptomsofmentalhealthdisordersaprospectivecohortofpatientswithseveresubstanceusedisordersinnorway